Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Effect of HIV Infection on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma

ABCL - 216

Effect of HIV Infection on Treatment Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Anastasia Galitsyna

Poster Presenter: Anastasia Galitsyna

Thumbnail for A Rare Case of Mediastinal Gray Zone Lymphoma Presenting With Tracheoesophageal Fistula

ABCL - 231

A Rare Case of Mediastinal Gray Zone Lymphoma Presenting With Tracheoesophageal Fistula

Ritwik Dey

Poster Presenter: Ritwik Dey

Thumbnail for Treatment Outcomes and Relapse Dynamics in Burkitt Lymphoma: Real-World Data From a National Latin American Reference Center

ABCL - 232

Treatment Outcomes and Relapse Dynamics in Burkitt Lymphoma: Real-World Data From a National Latin American Reference Center

Andy Yajaira Mejia-Castro

Poster Presenter: Andy Yajaira Mejia-Castro

Thumbnail for Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting

ABCL - 241

Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting

Barbara Furtado

Poster Presenter: Barbara Furtado

Thumbnail for Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated with Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study

ABCL - 257

Neutrophil-to-Lymphocyte Ratio and SIRI Are Associated with Survival and Relapse in Diffuse Large B-Cell Lymphoma: A Single-Center Study

Juliana Faleschini

Poster Presenter: Juliana Faleschini

Thumbnail for CXCR4 Expression as a Determinant of Inferior Outcomes Following CD19 CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis

ABCL - 285

CXCR4 Expression as a Determinant of Inferior Outcomes Following CD19 CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis

Albert Owusu-Ansah

Poster Presenter: Albert Owusu-Ansah

Thumbnail for Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

ABCL - 286

Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

Shahzeb Ahmed

Poster Presenter: Shahzeb Ahmed

Thumbnail for CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies

ABCL - 300

CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies

Albert Owusu-Ansah

Poster Presenter: Albert Owusu-Ansah

Thumbnail for waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

ABCL - 313

waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Melissa Drysdale

Poster Presenter: Melissa Drysdale